Towards Eradication of HIV-1: Therapeutic Vaccination with the Peptide-Based Candidate Vacc-4x, 2014

Human immunodeficiency virus (HIV)-1 infection continues to threaten global health with approximately 34 million adults and children living with HIV infection worldwide in 2010. Antiretroviral therapy (ART) has made a significant impact on HIV infection, however, since it cannot eradicate HIV, ART must be taken daily for life, thereby conferring a significant financial burden on healthcare services worldwide. The aim of this study was to test a cure against HIV by using Vacc-4x, a peptide-based therapeutic HIV vaccine. The study is registered at www.clinicaltrials.gov. For further information about "Towards Eradication of HIV-1: Therapeutic Vaccination with the Peptide-Based Candidate Vacc-4x, 2014", please contact the principal investigator.